SCHEDULE 13G/A

Beta Bionics Inc

Common Stock · CUSIP: 08659B102

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Sands Capital Life Sciences Pulse Fund II. L.P.

  Shares: 3,570,113.00 · Class: 8.2%

• Sands Capital Alternatives, LLC

  Shares: 3,570,113.00 · Class: 8.2%

• SANDS FRANK M.

  Shares: 3,570,113.00 · Class: 8.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.